Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01314950 · ClinicalTrials.gov registry record · NA

Alzheimer's Disease Multiple Intervention Trial

A NA study, sponsored by Indiana University.

Completed
Registry status
NA
Development phase
180
Enrollment target

NCT01314950: Completed NA study, sponsored by Indiana University.

NCT01314950 is a NA study that has completed, run by Indiana University. The registered enrollment target is 180 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01314950, a NA study, has completed, sponsored by Indiana University.

COMPLETED
Registry status
NA
Development phase
180 participants
Enrollment target

Study Summary

The purpose of this study is to conduct a two-year randomized, controlled clinical trial to improve functioning among older adults with Alzheimer's disease by comparing a control group receiving best practices primary care with an intervention group receiving best practice primary care plus a home-based occupational therapy intervention.

Interventions

  • BEHAVIORAL Home based occupational therapy
  • BEHAVIORAL Best practices primary care

Trial Details

FieldValue
Enrollment Target 180 participants
Start Date 2010-07
Est. Completion 2015-12
Phase NA
Indiana University

890 total trials

What the finished NCT01314950 record still lists

NCT01314950 is an interventional study that assigns participants to a tested intervention. The registered 180 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower).

The record links to 0 conditions, and to 2 interventions - of which Home based occupational therapy is the first listed.

NCT01314950 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01314950 about?

NCT01314950 is a clinical study titled "Alzheimer's Disease Multiple Intervention Trial". The purpose of this study is to conduct a two-year randomized, controlled clinical trial to improve functioning among older adults with Alzheimer's disease by comparing a control group receiving best practices primary care with an intervention group receiving best practice primary care plus a home-b...

What is the current status of trial NCT01314950?

This trial is currently completed. It is a NA study. The enrollment target is 180 participants. The study started on 2010-07. Estimated completion is 2015-12.

What interventions are being tested in trial NCT01314950?

The interventions under investigation include: Home based occupational therapy (BEHAVIORAL), Best practices primary care (BEHAVIORAL).

Who is sponsoring clinical trial NCT01314950?

This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01314950's enrollment target sits among peer trials

180 586th of 2000 higher than 1,397 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01558804 · 180 participants

    GRoup A StrePtococcus

  • NCT02932176 · 180 participants

    Machine Learning for Handheld Vascular Studies

  • NCT03384563 · 180 participants · Phase 4

    Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane

  • NCT03423628 · 180 participants · Phase 1

    A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01314950, the US trial registry maintained by the National Library of Medicine. NCT01314950 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.